TREACE MEDICAL CONCEPTS, INC. — Director's Dealing 2021

Apr 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK: 0001630627
Period of Report: 2021-04-27

Reporting Person: Owens Daniel E. (Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-27	Common	P	4000	$17.00	Acquired	4000	Direct